glutathione reducible linker induced cleavage of disulfide in the CyA based DD Unlocking the potential of antibody–drug
Description
and K.H
Medicare's database of paid claims from 1998 to 2002 shows a huge increase in the utilization of 67028, intravitreal injection of a pharmacological agent, separate procedure (Figure)
3-Bromopyruvate inhibits glycolysis, depletes cellular glutathione, and compromises the viability of cultured primary rat astrocytes
For a deeper comparison, see Reduced vs
